Unipolare Depression Langfassung - Versorgungsleitlinien.de
Unipolare Depression Langfassung - Versorgungsleitlinien.de
Unipolare Depression Langfassung - Versorgungsleitlinien.de
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
342. Stolk P, Ten Berg MJ, Hemels ME, Einarson TR. Meta-analysis of placebo rates in major<br />
<strong>de</strong>pressive disor<strong>de</strong>r trials. Ann Pharmacother 2003;37(12):1891-9.<br />
343. Khan A, Leventhal RM, Khan SR, Brown WA. Severity of <strong>de</strong>pression and response to<br />
anti<strong>de</strong>pressants and placebo: an analysis of the Food and Drug Administration database. J<br />
Clin Psychopharmacol 2002;22(1):40-5.<br />
344. Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilkonis PA, Leber<br />
WR, Docherty JP. National Institute of Mental Health Treatment of <strong>Depression</strong> Collaborative<br />
Research Program. General effectiveness of treatments. Arch Gen Psychiatry<br />
1989;46(11):971-82.<br />
345. Hamilton JA, Grant M, Jensvold MF. Sex and treatment of <strong>de</strong>pression. In: Jensvold MF,<br />
Halbreich U, Hamilton JA, editors. Psychopharmacology and women: sex, gen<strong>de</strong>r and<br />
hormones. Washington: Am. Psychiatric Pr.; 1996. p. 241-60<br />
346. Berlanga C, Flores-Ramos M. Different gen<strong>de</strong>r response to serotonergic and noradrenergic<br />
anti<strong>de</strong>pressants. A comparative study of the efficacy of citalopram and reboxetine. J Affect<br />
Disord 2006;95(1-3):119-23.<br />
347. Martenyi F, Dossenbach M, Mraz K, Metcalfe S. Gen<strong>de</strong>r differences in the efficacy of<br />
fluoxetine and maprotiline in <strong>de</strong>pressed patients: a double-blind trial of anti<strong>de</strong>pressants with<br />
serotonergic or norepinephrinergic reuptake inhibition profile. Eur Neuropsychopharmacol<br />
2001;11(3):227-32.<br />
348. Baca E, Garcia-Garcia M, Porras-Chavarino A. Gen<strong>de</strong>r differences in treatment response to<br />
sertraline versus imipramine in patients with nonmelancholic <strong>de</strong>pressive disor<strong>de</strong>rs. Prog<br />
Neuropsychopharmacol Biol Psychiatry 2004;28(1):57-65.<br />
349. Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg<br />
AJ, Davis SM, Harrison WM, Keller MB. Gen<strong>de</strong>r differences in treatment response to<br />
sertraline versus imipramine in chronic <strong>de</strong>pression. Am J Psychiatry 2000;157(9):1445-52.<br />
350. National Institute for Clinical Excellence (NICE), National Collaborating Centre for Mental<br />
Health. <strong>Depression</strong> in Adults (update). <strong>Depression</strong>: the treatment and management of<br />
<strong>de</strong>pression in adults. Draft for consultation Feb 2009. 2009 [cited: 2009 Okt 05]. Available<br />
from: http://www.nice.org.uk/nicemedia/pdf/<strong>Depression</strong>UpdateFullGuidlineDraft.pdf<br />
351. Hil<strong>de</strong>brandt MG, Steyerberg EW, Stage KB, Passchier J, Kragh-Soerensen P. Are gen<strong>de</strong>r<br />
differences important for the clinical effects of anti<strong>de</strong>pressants? Am J Psychiatry<br />
2003;160(9):1643-50.<br />
352. Papakostas GI, Montgomery SA, Thase ME, Katz JR, Krishen A, Tucker VL. Comparing the<br />
rapidity of response during treatment of major <strong>de</strong>pressive disor<strong>de</strong>r with bupropion and the<br />
SSRIs: a pooled survival analysis of 7 double-blind, randomized clinical trials. J Clin<br />
Psychiatry 2007;68(12):1907-12.<br />
353. Khan A, Sabel MS, Nees A, Diehl KM, Cimmino VM, Kleer CG, Schott AF, Hayes DF, Chang<br />
AE, Newman LA. Comprehensive axillary evaluation in neoadjuvant chemotherapy patients<br />
with ultrasonography and sentinel lymph no<strong>de</strong> biopsy. Ann Surg Oncol 2005;12(9):697-704.<br />
354. Nierenberg AA, Amsterdam JD. Treatment-resistant <strong>de</strong>pression: <strong>de</strong>finition and treatment<br />
approaches. J Clin Psychiatry 1990;51:39-47.<br />
355. Stassen HH, Angst J, Delini-Stula A. Delayed onset of action of anti<strong>de</strong>pressant drugs? Survey<br />
of results of Zurich meta-analyses. Eur Psychiatry 1997;12(4):166-76.<br />
356. Stassen HH, Angst J, Hell D, Scharfetter C, Szegedi A. Is there a common resilience<br />
mechanism un<strong>de</strong>rlying anti<strong>de</strong>pressant drug response? Evi<strong>de</strong>nce from 2848 patients. J Clin<br />
Psychiatry 2007;68(8):1195-205.<br />
357. Angst J, Stassen HH. Do anti<strong>de</strong>pressants really take several weeks to show effect? In:<br />
Leonard BE, editor. Anti<strong>de</strong>pressants. Basel: Birkhäuser; 2001. p. 21-30<br />
358. Stassen HH, Angst J, Delini-Stula A. Fluoxetine versus moclobemi<strong>de</strong>: cross-comparison<br />
between the time courses of improvement. Pharmacopsychiatry 1999;32(2):56-60.<br />
359. Khan A, Khan SR, Leventhal RM, Brown WA. Symptom reduction and suici<strong>de</strong> risk in patients<br />
treated with placebo in anti<strong>de</strong>pressant clinical trials: a replication analysis of the Food and<br />
Drug Administration Database. Int J Neuropsychopharmacol 2001;4(2):113-8.<br />
© 2009 218